1. Home
  2. NIO vs RGEN Comparison

NIO vs RGEN Comparison

Compare NIO & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NIO
  • RGEN
  • Stock Information
  • Founded
  • NIO 2014
  • RGEN 1981
  • Country
  • NIO China
  • RGEN United States
  • Employees
  • NIO N/A
  • RGEN N/A
  • Industry
  • NIO Auto Manufacturing
  • RGEN Medical/Dental Instruments
  • Sector
  • NIO Consumer Discretionary
  • RGEN Health Care
  • Exchange
  • NIO Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • NIO 7.4B
  • RGEN 8.0B
  • IPO Year
  • NIO 2018
  • RGEN N/A
  • Fundamental
  • Price
  • NIO $3.82
  • RGEN $118.15
  • Analyst Decision
  • NIO Hold
  • RGEN Buy
  • Analyst Count
  • NIO 6
  • RGEN 12
  • Target Price
  • NIO $5.05
  • RGEN $172.67
  • AVG Volume (30 Days)
  • NIO 32.2M
  • RGEN 842.8K
  • Earning Date
  • NIO 06-03-2025
  • RGEN 04-29-2025
  • Dividend Yield
  • NIO N/A
  • RGEN N/A
  • EPS Growth
  • NIO N/A
  • RGEN N/A
  • EPS
  • NIO N/A
  • RGEN N/A
  • Revenue
  • NIO $9,005,433,398.00
  • RGEN $650,429,000.00
  • Revenue This Year
  • NIO $37.90
  • RGEN $13.93
  • Revenue Next Year
  • NIO $26.13
  • RGEN $14.35
  • P/E Ratio
  • NIO N/A
  • RGEN N/A
  • Revenue Growth
  • NIO 18.18
  • RGEN 4.88
  • 52 Week Low
  • NIO $3.02
  • RGEN $102.97
  • 52 Week High
  • NIO $7.71
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • NIO 44.08
  • RGEN 38.20
  • Support Level
  • NIO $3.91
  • RGEN $120.11
  • Resistance Level
  • NIO $4.06
  • RGEN $129.42
  • Average True Range (ATR)
  • NIO 0.11
  • RGEN 6.02
  • MACD
  • NIO -0.02
  • RGEN -1.20
  • Stochastic Oscillator
  • NIO 15.09
  • RGEN 5.96

About NIO NIO Inc. American depositary shares each representing one ordinary share

Nio is a leading electric vehicle maker, targeting the premium segment. Founded in November 2014, Nio designs, develops, jointly manufactures, and sells premium smart electric vehicles. The company differentiates itself through continuous technological breakthroughs and innovations such as battery swapping and autonomous driving technologies. Nio launched its first model, its ES8 seven-seater electric SUV, in December 2017, and began deliveries in June 2018. Its current model portfolio includes midsize to large sedans and SUVs. It sold around 222,000 EVs in 2024, accounting for about 2% of the China passenger new energy vehicle market.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: